DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Brian Gormley Brian Gormley - 1 Luke Evnin - 1 drugmakers - 1 Evnin - 1 Sarah Needleman - 1 Zoe Thomas - 1 Brian Gormley - 1
Top related locs:
Amherst
Top related orgs:
Wall Street - 5 The Wall Street - 1 University of Massachusetts - 1 Boston University - 1 Scleroderma Research Foundation - 1 Microsoft - 1 Activision - 1 Micron Biomedical - 1

Search resuls for: "Brian Gormley"


14 mentions found


☆ Questa Capital Closes Healthcare Venture Fund at $397 Million
  + stars: | 2023-08-24 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Resume SubscriptionWe are delighted that you'd like to resume your subscription. You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.
Organizations: Wall Street
☆ Andreessen Co-Leads $200 Million Investment in Biotech Startup Genesis Therapeutics
  + stars: | 2023-08-21 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Resume SubscriptionWe are delighted that you'd like to resume your subscription. You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.
Organizations: Wall Street
☆ Neurological Devices Attract Investors Despite Cautious Venture Market
  + stars: | 2023-08-17 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Resume SubscriptionWe are delighted that you'd like to resume your subscription. You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.
Organizations: Wall Street
☆ Brian Gormley — Reporter at The Wall Street Journal
  + stars: | 2023-08-17 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Brian GormleyBrian Gormley covers venture capital and healthcare for The Wall Street Journal. He has bachelor's degrees in political science and journalism from the University of Massachusetts, Amherst, and a master's degree in journalism from Boston University.
Persons: Brian Gormley Brian Gormley Organizations: The Wall Street, University of Massachusetts, Boston University Locations: Amherst
☆ Biotech M&A Rebound Bodes Well for Venture Investors
  + stars: | 2023-08-10 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Resume SubscriptionWe are delighted that you'd like to resume your subscription. You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.
Organizations: Wall Street
☆ Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
  + stars: | 2023-08-01 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that he has himself. Through the Scleroderma Research Foundation, a nonprofit that funds scleroderma research, Evnin has launched a new clinical trial platform, called Conquest, designed to accelerate drug development for the disease. Scleroderma often causes tightening and thickening of skin, and can affect the heart,...
Persons: Luke Evnin, drugmakers, Evnin Organizations: Scleroderma Research Foundation
☆ Russia Says It Fended Off the Largest Ukrainian Assault in Months
  + stars: | 2023-06-05 | by ( ) www.wsj.com   time to read: 1 min
Why Call of Duty Could Stand in the Way of a $75 Billion DealGlobal regulators are concerned that if Microsoft acquires games publisher Activision Blizzard it could have an unfair advantage in the videogame industry, partly due to the popularity of Call of Duty. WSJ tech reporter Sarah Needleman joins host Zoe Thomas to explain what makes the Call of Duty franchise so successful. Plus, WSJ Pro reporter Brian Gormley discusses why patches that can deliver vaccines are attracting more investors. Photo: Activision
Persons: Sarah Needleman, Zoe Thomas, Brian Gormley Organizations: Microsoft, Activision
☆ Startups’ Patch Technologies Could Extend Reach of Vaccines
  + stars: | 2023-06-01 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
In several countries the effort to eradicate measles runs into the logistical obstacle of insufficient cold storage for vaccines. Patches from startups including Micron Biomedical and Vaxxas could overcome this difficulty and extend the reach of vaccines in nations where measles outbreaks occur because of relatively low vaccination rates. Measles vaccine doses are sensitive to heat and must be kept cold.
Organizations: Micron Biomedical
☆ Biotech Startups Use Models of Human Organs for Drug Discovery
  + stars: | 2023-04-20 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Resume SubscriptionWe are delighted that you'd like to resume your subscription. You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.
Organizations: Wall Street
☆ Healthcare Lenders See Increased Demand Amid Banking Crisis
  + stars: | 2023-04-03 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Resume SubscriptionWe are delighted that you'd like to resume your subscription. You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.
☆ Telemedicine Startups Wary of Regulatory Shift in War on Opioid Addiction
  + stars: | 2023-03-30 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Telemedicine companies are facing a regulatory shift that many entrepreneurs say would undercut their ability to quickly prescribe medication that helps prevent opioid overdoses. During the Covid-19 pandemic, telehealth companies benefited from a waiver of the requirement that patients be seen in-person before receiving a telemedicine prescription for buprenorphine, a controlled substance used to treat opioid addiction.
☆ Startups Take On Illumina in Race for Cheaper DNA Sequencing
  + stars: | 2023-02-16 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Resume SubscriptionWe are delighted that you'd like to resume your subscription. You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.
☆ JPMorgan Launches Life-Sciences Venture Group
  + stars: | 2022-11-01 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Resume SubscriptionWe are delighted that you'd like to resume your subscription. You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.
☆ Digital-Health Venture Funding Pulls Back from Last Year’s Rush
  + stars: | 2022-10-13 | by ( Brian Gormley | ) www.wsj.com   time to read: 1 min
Venture-capital investment in digital health is down from last year’s record pace and increasingly focused on startups to help healthcare providers operate more effectively, an industry report said. U.S. startups in digital health—including telemedicine, software-based therapeutics and technology to help medical practices function more efficiently—secured $2.2 billion in venture capital during the third quarter, according to Rock Health, a San Francisco-based venture investor and advisory firm. It was the slowest quarter for digital-health investment since the fourth quarter of 2019, when companies raised $2.1 billion, Rock Health said.
0 next >>
Total: 14